Michael Želı́zko

772 total citations
50 papers, 229 citations indexed

About

Michael Želı́zko is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Želı́zko has authored 50 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 16 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Želı́zko's work include Acute Myocardial Infarction Research (14 papers), Cardiac Valve Diseases and Treatments (12 papers) and Cardiovascular Function and Risk Factors (10 papers). Michael Želı́zko is often cited by papers focused on Acute Myocardial Infarction Research (14 papers), Cardiac Valve Diseases and Treatments (12 papers) and Cardiovascular Function and Risk Factors (10 papers). Michael Želı́zko collaborates with scholars based in Czechia, United States and Germany. Michael Želı́zko's co-authors include Michael Aschermann, Petr Widimský, Ladislav Groch, Jan Piťha, J Krupicka, Josef Kautzner, František Bednář, Ivan Netuka, Jiří Malý and Axel Haverich and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

Michael Želı́zko

37 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Želı́zko Czechia 8 143 111 68 50 33 50 229
Flavia Nicoli Italy 9 164 1.1× 111 1.0× 82 1.2× 17 0.3× 81 2.5× 19 255
Ramy Mando United States 8 130 0.9× 79 0.7× 62 0.9× 58 1.2× 16 0.5× 23 205
Iris P. Garrido‐Bravo Spain 9 105 0.7× 176 1.6× 155 2.3× 41 0.8× 8 0.2× 31 286
Choon Pin Lim Singapore 8 74 0.5× 104 0.9× 82 1.2× 40 0.8× 4 0.1× 20 226
Noemi Bruno Italy 7 143 1.0× 39 0.4× 35 0.5× 35 0.7× 17 0.5× 15 232
Nick Fisher New Zealand 6 127 0.9× 90 0.8× 80 1.2× 10 0.2× 128 3.9× 14 241
Bum Sung Kim South Korea 10 160 1.1× 132 1.2× 20 0.3× 24 0.5× 81 2.5× 26 222
Christopher P. Lawrance United States 12 236 1.7× 80 0.7× 50 0.7× 25 0.5× 17 0.5× 21 333
Andrew Lenneman United States 10 102 0.7× 191 1.7× 157 2.3× 57 1.1× 7 0.2× 31 284
Jessica Weimann Germany 8 132 0.9× 102 0.9× 92 1.4× 83 1.7× 18 0.5× 29 224

Countries citing papers authored by Michael Želı́zko

Since Specialization
Citations

This map shows the geographic impact of Michael Želı́zko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Želı́zko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Želı́zko more than expected).

Fields of papers citing papers by Michael Želı́zko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Želı́zko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Želı́zko. The network helps show where Michael Želı́zko may publish in the future.

Co-authorship network of co-authors of Michael Želı́zko

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Želı́zko. A scholar is included among the top collaborators of Michael Želı́zko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Želı́zko. Michael Želı́zko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wohlfahrt, Peter, Dominik Jenča, Vojtěch Melenovský, et al.. (2024). Remote Heart Failure Symptoms Assessment After Myocardial Infarction Identifies Patients at Risk for Death. Journal of the American Heart Association. 13(2). e032505–e032505. 2 indexed citations
2.
Jenča, Dominik, Vojtěch Melenovský, Marek Šramko, et al.. (2024). Iron deficiency and all-cause mortality after myocardial infarction. European Journal of Internal Medicine. 126. 102–108. 7 indexed citations
3.
Wohlfahrt, Peter, Dominik Jenča, Vojtěch Melenovský, et al.. (2024). Development and validation of a prognostic score integrating remote heart failure symptoms and clinical variables in mortality risk prediction after myocardial infarction: the PragueMi score. European Journal of Preventive Cardiology. 31(14). 1713–1720.
4.
Wohlfahrt, Peter, Dominik Jenča, Vojtěch Melenovský, et al.. (2024). Remote, Smart Device-Based Cardiac Rehabilitation After Myocardial Infarction: A Pilot, Randomized Cross-Over SmartRehab Study. SHILAP Revista de lepidopterología. 2(3). 352–360. 1 indexed citations
5.
Wohlfahrt, Peter, Dominik Jenča, Vojtěch Melenovský, et al.. (2023). Attenuation of Hypocretin/Orexin Signaling Is Associated With Increased Mortality After Myocardial Infarction. Journal of the American Heart Association. 12(6). e028987–e028987. 3 indexed citations
6.
Želı́zko, Michael, et al.. (2023). Transcatheter treatment of mitral regurgitation. 22(1). 27–34.
7.
Moťovská, Zuzana, Ota Hlinomaz, Michael Aschermann, et al.. (2023). Trends in outcomes of women with myocardial infarction undergoing primary angioplasty—Analysis of randomized trials. Frontiers in Cardiovascular Medicine. 9. 953567–953567. 4 indexed citations
8.
Wohlfahrt, Peter, Dominik Jenča, Josef Stehlik, et al.. (2022). Heart failure-related quality-of-life impairment after myocardial infarction. Clinical Research in Cardiology. 112(1). 39–48. 9 indexed citations
9.
Wohlfahrt, Peter, Dominik Jenča, Vojtěch Melenovský, et al.. (2021). Very low lipoprotein(a) and increased mortality risk after myocardial infarction. European Journal of Internal Medicine. 91. 33–39. 11 indexed citations
10.
11.
Kotrč, Martin, et al.. (2018). MitraClip in patients with functional mitral regurgitation and advanced heart failure - Single centre experience. Cor et Vasa. 61(1). 8–14. 1 indexed citations
12.
Kautzner, Josef, Ivan Málek, A Jabor, et al.. (2017). Early progression of cardiac allograft vasculopathy assessed by quantitative coronary angiography: A single centre prospective study. Cor et Vasa. 60(1). e59–e65.
13.
Toušek, Petr, František Toušek, Michael Želı́zko, et al.. (2017). Trends in the treatment and outcomes of elderly patients with acute coronary syndrome: Results from the CZECH registries. Cor et Vasa. 60(1). e66–e69. 1 indexed citations
14.
Želı́zko, Michael, et al.. (2016). Catheter occlusion of pseudoaneurysm of ascending aorta after Bentall's procedure in patient with Marfan's syndrome. 15(4). 191–192. 1 indexed citations
15.
Želı́zko, Michael, et al.. (2016). Aortic stenosis: new indications for transcatheter aortic valve implantation. 15(1). 19–25. 1 indexed citations
16.
Želı́zko, Michael, et al.. (2016). Percutaneous intervention in chronic mitral regurgitation. 15(1). 26–32. 1 indexed citations
17.
Bláha, M., Petr Kala, Ivo Bernát, et al.. (2014). [The user´s reporting from the national registry of catheter aortic valve implantations (Czech TAVI Registry): the possibilities of the analytical reports based on the database system TrialDB2].. PubMed. 60(10). 837–45.
18.
Toušek, Petr, David Hořák, František Toušek, et al.. (2014). Trends in epidemiology and the treatment of acute coronary syndromes in the Czech Republic: Comparison of the CZECH-1 and CZECH-2 registries. Cor et Vasa. 56(4). e285–e290. 2 indexed citations
19.
Hradec, J, Jan Bultas, & Michael Želı́zko. (2010). Stabilní angina pectoris. Doporučený diagnostický a léčebný postup České kardiologické společnosti. Cor et Vasa. 52(9). 543–561. 2 indexed citations
20.
Widimský, Petr, Zuzana Moťovská, Dana Bilkova, et al.. (2007). The impact of age and Killip class on outcomes of primary percutaneous coronary intervention. Insight from the PRAGUE-1 and -2 trials and registry.. PubMed. 2(4). 481–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Flavia Nicoli Breakdown of academic impact, for papers by Ramy Mando Breakdown of academic impact, for papers by Iris P. Garrido‐Bravo Breakdown of academic impact, for papers by Choon Pin Lim Breakdown of academic impact, for papers by Noemi Bruno Breakdown of academic impact, for papers by Nick Fisher Breakdown of academic impact, for papers by Bum Sung Kim Breakdown of academic impact, for papers by Christopher P. Lawrance Breakdown of academic impact, for papers by Andrew Lenneman Breakdown of academic impact, for papers by Jessica Weimann
Rankless by CCL
2026